MRNA short – End of the Covid Trade
In late December 2021, I identified an extremely overbought condition and potential short entry on Moderna and Pfizer, after a year of extraordinary gains due to covid products. Omicron was beginning to take hold and showing much lower risk, and much higher transmission which would potentially plummet the demand for their existing products. I posted and timed the top almost perfectly, coinciding with a 2000%+ return on the posted options, and over 100k USD in profit within 30 days.
